State Street’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $205K | Sell |
|
|||||
|
2025
Q2 | $64.1K | Hold |
|
|||||
|
2025
Q1 | $28.8K | Hold |
|
|||||
|
2024
Q4 | $55.5K | Buy |
|
|||||
|
2024
Q3 | $322K | Sell |
|
|||||
|
2024
Q2 | $318K | Sell |
|
|||||
|
2024
Q1 | $517K | Sell |
|
|||||
|
2023
Q4 | $477K | Hold |
|
|||||
|
2023
Q3 | $346K | Sell |
|
|||||
|
2023
Q2 | $318K | Sell |
|
|||||
|
2023
Q1 | $1.25M | Buy |
|
|||||
|
2022
Q4 | $1.73M | Sell |
|
|||||
|
2022
Q3 | $21.8M | Sell |
|
|||||
|
2022
Q2 | $11.4M | Buy |
|
|||||
|
2022
Q1 | $12M | Buy |
|
|||||
|
2021
Q4 | $7.29M | Sell |
|
|||||
|
2021
Q3 | $8.54M | Buy |
|
|||||
|
2021
Q2 | $9.93M | Buy |
|
|||||
|
2021
Q1 | $10.2M | Sell |
|
|||||
|
2020
Q4 | $9.76M | Buy |
|
|||||
|
2020
Q3 | $11.4M | Buy |
|
|||||
|
2020
Q2 | $12.7M | Buy |
|
|||||
|
2020
Q1 | $287K | Buy |
|